ICMR allows states to make use of local labs

PUNE: The ICMR has allowed states to take help of local laboratories and not just depend on the National Accreditation Board for Testing and Calibration Laboratories (NABL)-accredited facilities to carry out the rapid antigen tests. As many as 1,751 laboratories in the country are currently conducting tests. “Every state has the right to take a decision on the rapid antigen tests, as it does not require a sophisticated laboratory setting,” a senior Indian Council of Medical Research (ICMR) official said on Friday. “The first Covid-19 swab sample was tested on January 23 at the ICMR laboratory. Now, we have 1,751 laboratories — 1,059 are run by the government and 692 are private facilities,” the official said. On an average, the country is conducting one million tests a day to diagnose Covid-19 cases for the past three weeks. ....read more

Instrumental Music to Cope With COVID Stress

Listening to music can have a relaxing effect on our minds and bodies, particularly slow, classical music. Join us on MEDtalks with Dr K K Aggarwal on Sunday, September 20 at 7:00 PM to know more about how instrumental music can help us cope with stress during the current times.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php

CMAAO Coronavirus Facts and Myth Buster: SARS-CoV-2 serologic testing

With input from Dr Monica Vasudev 1086:New guidelines from IDSA on use of SARS-CoV-2 serologic testing in a variety of settingsDG Alerts: The Infectious Diseases Society of America (IDSA) has published evidence-based recommendations for the optimal use of COVID-19 serologic tests. The guideline is published in Clinical Infectious Diseases. The guideline panel agreed on 8 diagnostic recommendations:The panel suggests against using serologic testing for the diagnosis of COVID-19 infection during the first 2 weeks (14 days) following symptom onset (conditional recommendation, very low certainty of evidence). ....read more

World COVID Meter 19th September: Acute manageable immunogenic thrombogenic inflammatory viral disease pandemic

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1, 19M August 6, 20M August 10, 21M August 16, 22M August 19, 23M August 21, 24M August 27, 25M August 30, 26M September 3, 27M September 7, 28M September 10, 29M September 14, 30M September 18 Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity Coronavirus Cases: 30,690,576,Deaths: 956,350,Recovered: 22,333,057,ACTIVE CASES 7,401,169,Currently Infected Patients 7,339,768 (99%) in Mild Condition ....read more

Why do we light a lamp during pooja?

Prayer|| Deepajyothi parabrahmaDeepa Jyotir JanaardanahDeepo harati paapaaniSandhyaa deepa namostute ||"I prostrate to the dawn/dusk lamp; whose light is the Knowledge Principle (the Supreme Lord), which removes the darkness of ignorance and by which all can be achieved in life." ....read more

Video of The day

Viral Load, Universal Masking and Variolation

Healthcare News Monitor

Canadian Pharma Companys Cannabis-Based Drug Could Treat COVID-19 Side Effects

indiatimes

Akseera Pharma, a Canadian startup, is working on bringing drugs based on cannabis -- specifically Cannabidiol -- a compound derived from Cannabis to treat patients with cardiac damage caused due to COVID-19. The pharmaceutical company is currently in talks with the government to commence clinical trials and manufacturing of cannabidiol in India.

Oxford COVID-19 vaccine: Serum Institute to start final phase of trial from Monday

LiveMint

The Serum Institute of India is all set to begin the final stage of the clinical trial of University of Oxford and AstraZeneca Plc.’s experimental vaccine, starting from next week. The late-stage trial will take place at the Sassoon General Hospital in Pune, according to news agency PTI. "The phase III trial of Covishield vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday." Dr Muralidhar Tambe, Dean of Sassoon General Hospital, told the news agency.

Doctors find improved early psychosis detection system may halve risk in young people

ETHealth

Washington D.C. [USA], September 19 (ANI): To detect emerging psychosis in younger people, doctors have developed a new data mining method. The new method, based on advanced data mining to pick up early risk signs from schools, hospitals, and general doctors, will be presented at the ECNP virtual congress and is in press with a peer-reviewed journal. Psychosis is a condition that causes you to lose touch with reality, causing you to suffer from hallucinations or delusions. There are a variety of possible causes, including migration and social stress, trauma, substance abuse, etc. It represents a significant care burden, affecting about 20 million people and costing Europe around EUR94 billion every year (2011 estimate).